The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Vaccines & Vaccination-Global Market Insights and Sales Trends 2024
Synopsis
The global Vaccines & Vaccination market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Vaccines & Vaccination in various end use industries. The expanding demands from the Baby Vaccine, Adult Special Vaccine and Other,, are propelling Vaccines & Vaccination market. Subunit vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Live attenuated vaccines segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Vaccines & Vaccination market, driven by demand from China, the second largest economy with some signs of stabilising, the Vaccines & Vaccination market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vaccines & Vaccination, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vaccines & Vaccination market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vaccines & Vaccination market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vaccines & Vaccination sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vaccines & Vaccination covered in this report include Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med, CSL, Emergent BioSolutions and GSK, etc.
The global Vaccines & Vaccination market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
AstraZeneca
Bavarian Nordic
Novartis
Bharat Biotech
Bio-Med
CSL
Emergent BioSolutions
GSK
Johnson & Johnson
Pfizer
Merck
Sanofi
Global Vaccines & Vaccination market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vaccines & Vaccination market, Segment by Type:
Subunit vaccines
Live attenuated vaccines
Conjugate vaccines
Inactivated vaccines
Recombinant vector vaccines
Toxoid vaccines
Synthetic vaccines
Dendritic cell vaccines
Global Vaccines & Vaccination market, by Application
Baby Vaccine
Adult Special Vaccine
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Vaccines & Vaccination companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Vaccines & Vaccination market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Vaccines & Vaccination in various end use industries. The expanding demands from the Baby Vaccine, Adult Special Vaccine and Other,, are propelling Vaccines & Vaccination market. Subunit vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Live attenuated vaccines segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Vaccines & Vaccination market, driven by demand from China, the second largest economy with some signs of stabilising, the Vaccines & Vaccination market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vaccines & Vaccination, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vaccines & Vaccination market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vaccines & Vaccination market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vaccines & Vaccination sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vaccines & Vaccination covered in this report include Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med, CSL, Emergent BioSolutions and GSK, etc.
The global Vaccines & Vaccination market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
AstraZeneca
Bavarian Nordic
Novartis
Bharat Biotech
Bio-Med
CSL
Emergent BioSolutions
GSK
Johnson & Johnson
Pfizer
Merck
Sanofi
Global Vaccines & Vaccination market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vaccines & Vaccination market, Segment by Type:
Subunit vaccines
Live attenuated vaccines
Conjugate vaccines
Inactivated vaccines
Recombinant vector vaccines
Toxoid vaccines
Synthetic vaccines
Dendritic cell vaccines
Global Vaccines & Vaccination market, by Application
Baby Vaccine
Adult Special Vaccine
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Vaccines & Vaccination companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Vaccines & Vaccination
1.1 Vaccines & Vaccination Market Overview
1.1.1 Vaccines & Vaccination Product Scope
1.1.2 Vaccines & Vaccination Market Status and Outlook
1.2 Global Vaccines & Vaccination Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Vaccines & Vaccination Market Size by Region (2018-2029)
1.4 Global Vaccines & Vaccination Historic Market Size by Region (2018-2023)
1.5 Global Vaccines & Vaccination Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Vaccines & Vaccination Market Size (2018-2029)
1.6.1 North America Vaccines & Vaccination Market Size (2018-2029)
1.6.2 Europe Vaccines & Vaccination Market Size (2018-2029)
1.6.3 Asia-Pacific Vaccines & Vaccination Market Size (2018-2029)
1.6.4 Latin America Vaccines & Vaccination Market Size (2018-2029)
1.6.5 Middle East & Africa Vaccines & Vaccination Market Size (2018-2029)
2 Vaccines & Vaccination Market by Type
2.1 Introduction
2.1.1 Subunit vaccines
2.1.2 Live attenuated vaccines
2.1.3 Conjugate vaccines
2.1.4 Inactivated vaccines
2.1.5 Recombinant vector vaccines
2.1.6 Toxoid vaccines
2.1.7 Synthetic vaccines
2.1.8 Dendritic cell vaccines
2.2 Global Vaccines & Vaccination Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Vaccines & Vaccination Historic Market Size by Type (2018-2023)
2.2.2 Global Vaccines & Vaccination Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Vaccines & Vaccination Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Vaccines & Vaccination Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Vaccines & Vaccination Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Vaccines & Vaccination Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Vaccines & Vaccination Revenue Breakdown by Type (2018-2029)
3 Vaccines & Vaccination Market Overview by Application
3.1 Introduction
3.1.1 Baby Vaccine
3.1.2 Adult Special Vaccine
3.1.3 Other
3.2 Global Vaccines & Vaccination Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Vaccines & Vaccination Historic Market Size by Application (2018-2023)
3.2.2 Global Vaccines & Vaccination Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Vaccines & Vaccination Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Vaccines & Vaccination Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Vaccines & Vaccination Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Vaccines & Vaccination Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Vaccines & Vaccination Revenue Breakdown by Application (2018-2029)
4 Vaccines & Vaccination Competition Analysis by Players
4.1 Global Vaccines & Vaccination Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccines & Vaccination as of 2022)
4.3 Date of Key Players Enter into Vaccines & Vaccination Market
4.4 Global Top Players Vaccines & Vaccination Headquarters and Area Served
4.5 Key Players Vaccines & Vaccination Product Solution and Service
4.6 Competitive Status
4.6.1 Vaccines & Vaccination Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Vaccines & Vaccination Products, Services and Solutions
5.1.4 Abbott Vaccines & Vaccination Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 AstraZeneca
5.2.1 AstraZeneca Profile
5.2.2 AstraZeneca Main Business
5.2.3 AstraZeneca Vaccines & Vaccination Products, Services and Solutions
5.2.4 AstraZeneca Vaccines & Vaccination Revenue (US$ Million) & (2018-2023)
5.2.5 AstraZeneca Recent Developments
5.3 Bavarian Nordic
5.3.1 Bavarian Nordic Profile
5.3.2 Bavarian Nordic Main Business
5.3.3 Bavarian Nordic Vaccines & Vaccination Products, Services and Solutions
5.3.4 Bavarian Nordic Vaccines & Vaccination Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis Vaccines & Vaccination Products, Services and Solutions
5.4.4 Novartis Vaccines & Vaccination Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis Recent Developments
5.5 Bharat Biotech
5.5.1 Bharat Biotech Profile
5.5.2 Bharat Biotech Main Business
5.5.3 Bharat Biotech Vaccines & Vaccination Products, Services and Solutions
5.5.4 Bharat Biotech Vaccines & Vaccination Revenue (US$ Million) & (2018-2023)
5.5.5 Bharat Biotech Recent Developments
5.6 Bio-Med
5.6.1 Bio-Med Profile
5.6.2 Bio-Med Main Business
5.6.3 Bio-Med Vaccines & Vaccination Products, Services and Solutions
5.6.4 Bio-Med Vaccines & Vaccination Revenue (US$ Million) & (2018-2023)
5.6.5 Bio-Med Recent Developments
5.7 CSL
5.7.1 CSL Profile
5.7.2 CSL Main Business
5.7.3 CSL Vaccines & Vaccination Products, Services and Solutions
5.7.4 CSL Vaccines & Vaccination Revenue (US$ Million) & (2018-2023)
5.7.5 CSL Recent Developments
5.8 Emergent BioSolutions
5.8.1 Emergent BioSolutions Profile
5.8.2 Emergent BioSolutions Main Business
5.8.3 Emergent BioSolutions Vaccines & Vaccination Products, Services and Solutions
5.8.4 Emergent BioSolutions Vaccines & Vaccination Revenue (US$ Million) & (2018-2023)
5.8.5 Emergent BioSolutions Recent Developments
5.9 GSK
5.9.1 GSK Profile
5.9.2 GSK Main Business
5.9.3 GSK Vaccines & Vaccination Products, Services and Solutions
5.9.4 GSK Vaccines & Vaccination Revenue (US$ Million) & (2018-2023)
5.9.5 GSK Recent Developments
5.10 Johnson & Johnson
5.10.1 Johnson & Johnson Profile
5.10.2 Johnson & Johnson Main Business
5.10.3 Johnson & Johnson Vaccines & Vaccination Products, Services and Solutions
5.10.4 Johnson & Johnson Vaccines & Vaccination Revenue (US$ Million) & (2018-2023)
5.10.5 Johnson & Johnson Recent Developments
5.11 Pfizer
5.11.1 Pfizer Profile
5.11.2 Pfizer Main Business
5.11.3 Pfizer Vaccines & Vaccination Products, Services and Solutions
5.11.4 Pfizer Vaccines & Vaccination Revenue (US$ Million) & (2018-2023)
5.11.5 Pfizer Recent Developments
5.12 Merck
5.12.1 Merck Profile
5.12.2 Merck Main Business
5.12.3 Merck Vaccines & Vaccination Products, Services and Solutions
5.12.4 Merck Vaccines & Vaccination Revenue (US$ Million) & (2018-2023)
5.12.5 Merck Recent Developments
5.13 Sanofi
5.13.1 Sanofi Profile
5.13.2 Sanofi Main Business
5.13.3 Sanofi Vaccines & Vaccination Products, Services and Solutions
5.13.4 Sanofi Vaccines & Vaccination Revenue (US$ Million) & (2018-2023)
5.13.5 Sanofi Recent Developments
6 North America
6.1 North America Vaccines & Vaccination Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Vaccines & Vaccination Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Vaccines & Vaccination Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Vaccines & Vaccination Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Vaccines & Vaccination Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Vaccines & Vaccination Market Dynamics
11.1 Vaccines & Vaccination Industry Trends
11.2 Vaccines & Vaccination Market Drivers
11.3 Vaccines & Vaccination Market Challenges
11.4 Vaccines & Vaccination Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
